ADR Reporting Through Twitter from Patient Perspective
2018
- 119Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage119
- Abstract Views78
- Downloads41
Artifact Description
Adverse Drug Reaction (ADR) has become a central concern for many healthcare providers (FDA, \ 2016). It is well known that adverse reactions to drugs are a reason for several health problems. According \ to the Food and Drug Administration (FDA) estimation, ADRs are the 4th leading cause of death. The \ prevalence of ADRs demands a simple ADR reporting process. The ADR reporting process involves many \ stakeholders such as the FDA, the patient, and the health professional. The research uncovered a \ significant lack of communication among the stakeholders, thus the research goal is to improve this lack \ of communication. This research paper is an extension of a previous research in progress; Toward \ Improving Adverse Drug Reactions Reporting From Twitter (Alghamdi S, & Mujallid O, 2016); that \ provided the research problem, method, methodology, and designs the artifacts. This paper provides \ iterations of the design process, evaluation and presented findings as a descriptive analysis.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know